---
title: "Halcinonide - Primary Cutaneous T-Cell Lymphoma"
sidebar: mydoc_sidebar
permalink: db06786-mesh-d016410-1.html
toc: false 
---


Path ID: `DB06786_MESH_D016410_1`
{% include image.html url="images/db06786-mesh-d016410-1.png" file="db06786-mesh-d016410-1.png" alt="db06786-mesh-d016410-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D006206 | halcinonide | Drug |
| UniProt:P04150 | Glucocorticoid receptor | Protein |
| HP:0011123 | Inflammatory abnormality of the skin | PhenotypicFeature |
| MESH:D016410 | Primary cutaneous T-cell lymphoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Halcinonide | POSITIVELY REGULATES | Glucocorticoid Receptor |
| Glucocorticoid Receptor | NEGATIVELY CORRELATED WITH | Inflammatory Abnormality Of The Skin |
| Inflammatory Abnormality Of The Skin | MANIFESTATION OF | Primary Cutaneous T-Cell Lymphoma |
|---------|-----------|---------|

Reference: 
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200845/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200845/)
  - [https://en.wikipedia.org/wiki/Halcinonide](https://en.wikipedia.org/wiki/Halcinonide)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/443943#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/443943#section=Mechanism-of-Action)
  - [https://en.wikipedia.org/wiki/Corticosteroid#Pharmacology](https://en.wikipedia.org/wiki/Corticosteroid#Pharmacology)
  - [https://en.wikipedia.org/wiki/Cutaneous_T_cell_lymphoma#Signs_and_symptoms](https://en.wikipedia.org/wiki/Cutaneous_T_cell_lymphoma#Signs_and_symptoms)
